TY - JOUR
T1 - A New Preoperative Scoring System for Predicting Aggressiveness of Non-Functioning Pancreatic Neuroendocrine Neoplasms
AU - Takikawa, Tetsuya
AU - Kikuta, Kazuhiro
AU - Hamada, Shin
AU - Kume, Kiyoshi
AU - Miura, Shin
AU - Yoshida, Naoki
AU - Tanaka, Yu
AU - Matsumoto, Ryotaro
AU - Ikeda, Mio
AU - Kataoka, Fumiya
AU - Sasaki, Akira
AU - Hayashi, Hidehiro
AU - Hatta, Waku
AU - Ogata, Yohei
AU - Nakagawa, Kei
AU - Unno, Michiaki
AU - Masamune, Atsushi
N1 - Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2
Y1 - 2022/2
N2 - The management of non-functioning pancreatic neuroendocrine neoplasms (NF-Pan-NENs) is still controversial. This study aimed to develop a new scoring system for treatment decisions at initial diagnosis based on the identification of the predictive factors for aggressive NF-Pan-NENs. Seventy-seven patients who had been pathologically diagnosed with NF-PanNENs were en-rolled. We retrospectively reviewed 13 variables that could be assessed preoperatively. Univariate and multivariate stepwise logistic regression analyses were performed to identify factors for the aggressiveness of NF-PanNENs, and a scoring system was developed by assigning weighted points proportional to their β regression coefficient. Tumor size > 20 mm on contrast-enhanced computed tomography, tumor non-vascularity, and Ki-67 labeling index ≥5% on endoscopic ultrasound-guided fine-needle aspiration specimens were identified as independent factors for predicting the aggressiveness of NF-PanNENs. The new scoring system, developed using the identified factors, had an excellent discrimination ability, with area under the curve of 0.92 (95% CI, 0.85–0.99), and good calibration (p = 0.72, Hosmer-Lemeshow test). Ten-year overall survival rates in low-risk (0 point), intermediate-risk (1 to 2 points), and high-risk (3 to 4 points) groups were 100%, 90.9%, and 24.3%, respectively. This new scoring system would be useful for treatment decisions and prognostic prediction at initial diagnosis.
AB - The management of non-functioning pancreatic neuroendocrine neoplasms (NF-Pan-NENs) is still controversial. This study aimed to develop a new scoring system for treatment decisions at initial diagnosis based on the identification of the predictive factors for aggressive NF-Pan-NENs. Seventy-seven patients who had been pathologically diagnosed with NF-PanNENs were en-rolled. We retrospectively reviewed 13 variables that could be assessed preoperatively. Univariate and multivariate stepwise logistic regression analyses were performed to identify factors for the aggressiveness of NF-PanNENs, and a scoring system was developed by assigning weighted points proportional to their β regression coefficient. Tumor size > 20 mm on contrast-enhanced computed tomography, tumor non-vascularity, and Ki-67 labeling index ≥5% on endoscopic ultrasound-guided fine-needle aspiration specimens were identified as independent factors for predicting the aggressiveness of NF-PanNENs. The new scoring system, developed using the identified factors, had an excellent discrimination ability, with area under the curve of 0.92 (95% CI, 0.85–0.99), and good calibration (p = 0.72, Hosmer-Lemeshow test). Ten-year overall survival rates in low-risk (0 point), intermediate-risk (1 to 2 points), and high-risk (3 to 4 points) groups were 100%, 90.9%, and 24.3%, respectively. This new scoring system would be useful for treatment decisions and prognostic prediction at initial diagnosis.
KW - Endoscopic ultrasound-guided fine-needle aspiration
KW - Ki-67
KW - Pancreatic cancer
KW - Pancreatic neuroendocrine neoplasm
KW - Prediction model
UR - http://www.scopus.com/inward/record.url?scp=85124089488&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124089488&partnerID=8YFLogxK
U2 - 10.3390/diagnostics12020397
DO - 10.3390/diagnostics12020397
M3 - Article
AN - SCOPUS:85124089488
SN - 2075-4418
VL - 12
JO - Diagnostics
JF - Diagnostics
IS - 2
M1 - 397
ER -